Skip to main content

Microbiome and Cancer

Edited by:   Christopher Staley, University of Minnesota, USA (BMC Microbiology) 
                   Jacques Ravel, University of Maryland, USA (Microbiome)
                   Sean Devlin, Memorial Sloan-Kettering Cancer Center, USA (BMC Cancer)
                   

New Content Item

BMC CancerBMC Microbiology and Microbiome invite submissions to the ‘Microbiome and Cancer’ collection.

With microbiome research moving from a predominantly data-driven field towards understanding its contribution at a more mechanistic level, the impact of the microbiome on health and human disease has surfaced. At the same time, cancer research has diversified its approach with increasing emphasis for a multifaceted treatment model to ensure effective treatment towards a cure. As the intersection of the two fields, the role of the microbiome in cancer disease predisposition, risk, initiation, progression, diagnosis, prognosis and treatment is becoming increasingly apparent and a new focus of research. In recognition of this important and growing field of research, we hereby welcome submissions on ‘Microbiome and cancer’ aiming to present a collection of primary research articles and reviews on the topic. 

We invite submissions from all aspects of this developing field including but not limited to: 

  • reports on the cancer microbiome, 
  • effect of the microbiome on cancer initiation, tumorigenesis and progression
  • microbiome-driven increased cancer risk or predisposition 
  • the evolving role of microbiome modulation products
  • microbiome-driven changes in the metabolic and physiologic states in the tumor microenvironment,
  • biology of cancers triggered by microbiome-driven immune modulations
  • metabolomics and metagenomic studies at the interface of microbiome and cancer
  • the microbiome as a diagnostic/prognostic indicator for cancer
  • the effect of gut and tissue microbiomes on cancer therapy
  • the role of the cancer microbiome in therapy resistance

Working together: We would like to ensure your manuscript is placed in the most appropriate journal within this collection and, for this reason, the Editors may suggest your manuscript be transferred to another journal within the collection for review. Each manuscript will undergo peer review as normal in the appropriate journal and be included in this collection upon publication.

To submit to BMC Cancer please click here. See our journal submission guidelines.
To submit to BMC Microbiology please click here. See our journal submission guidelines.
To submit to Microbiome please click here. See our journal submission guidelines.

For pre-submission enquiries for the collection contact Linda Gummlich (for BMC Cancer), Akila Sridhar (for BMC Microbiology) or Srimathy Sriskantharajah (for Microbiome)


Our Guest Editors:


Christopher Staley

New Content ItemThe intestinal microbiota is a vital organ critical to the development, functioning, and health of the human the host. The Staley Lab at University of Minnesota research focus is to characterize how disruptions in this community affect the onset and progression of diseases and conditions e.g., obesity, colorectal cancer, and inflammatory bowel diseases. By applying microbial ecology principles and leveraging next-generation sequencing technologies, their goal is to develop targeted, microbiota-based therapies to improve patient outcomes. Chris is a Senior Board Member for BMC Microbiology.


Sean Devlin

New Content ItemSean Devlin is a Assistant Professor in Biostatistics as Memorial Sloan Kettering Cancer Centre. His research interests are in the development of adaptive and nonparametric regression methods for cancer research. He was involved in developing a novel algorithm to refine and improve the discriminatory ability of an existing prognostic classifier by incorporating new genomic markers for censored survival data. His current research interests also include developing risk scores for high dimensional survival data when multiple markers may predict treatment response. Sean is a Senior Board Member for BMC Cancer


Collection articles:

  1. Regulatory T cells (Tregs) play an important role in the antitumor immune response in epithelial ovarian cancer (EOC). To understand the immune-inhibitory networks of EOC, we addressed the association between ...

    Authors: Sho Sato, Hirokazu Matsushita, Daisuke Shintani, Yukari Kobayashi, Nao Fujieda, Akira Yabuno, Tadaaki Nishikawa, Keiichi Fujiwara, Kazuhiro Kakimi and Kosei Hasegawa
    Citation: BMC Cancer 2022 22:437
  2. Lymph node (LN) status is a key prognostic factor in the decision-making process of different cancer entities, including prostate cancer (PCa). Sectioning and haematoxylin and eosin (H&E) staining technique re...

    Authors: Mercè Cuadras, Jacques Planas, Ana Celma, Lucas Regis, Inés M. de Torres, M. Eugenia Semidey, Enrique Trilla and Juan Morote
    Citation: BMC Cancer 2022 22:357
  3. Archaea form a third domain of life that is distinct from Bacteria and Eukarya. So far, many scholars have elucidated considerable details about the typical promoter architectures of the three domains of life....

    Authors: Jinye Liang, Zhenghui Quan, Jianyu Zhu, Min Gan and Ping Shen
    Citation: BMC Microbiology 2022 22:79
  4. Cancer patients experience gastrointestinal and behavioral symptoms, and are at increased risk of systemic infection and inflammation. These conditions are a major source of morbidity and decreased quality of ...

    Authors: Brett R. Loman, Kathryn L. G. Russart, Corena V. Grant, Alexis J. Lynch, Michael T. Bailey and Leah M. Pyter
    Citation: BMC Cancer 2022 22:245
  5. Both modified FOLFIRINOX (mFFX) and gemcitabine/nab-paclitaxel chemotherapy regimens have been shown to improve clinical outcomes in patients with pancreatic cancer, and are often used interchangeably as the stan...

    Authors: Abagail M. Delahoussaye, Joseph Abi Jaoude, Morgan Green, Tara N. Fujimoto, Jessica Molkentine, Carolina J. Garcia Garcia, Jason P. Gay, Ningping Feng, Joseph Marszalek, Natalie Fowlkes and Cullen M. Taniguchi
    Citation: BMC Cancer 2022 22:174
  6. Cancer impacts millions of lives globally each year, with approximately 10 million cancer-related deaths recorded worldwide in 2020. Mounting research has recognised the human microbiome as a key area of inter...

    Authors: Claire M. Doocey, Karen Finn, Craig Murphy and Caitriona M. Guinane
    Citation: BMC Microbiology 2022 22:53
  7. Female sex workers (FSWs) are a marginalized group notoriously having limited healthcare access and poor-quality care. Inevitably, they are vulnerable to sexually transmitted infections including hepatitis B v...

    Authors: Deresse Daka, Getahun Hailemeskel and Demissie Assegu Fenta
    Citation: BMC Microbiology 2022 22:37
  8. The gut microbiome is implicated as a marker of response to  immune checkpoint inhibitors (ICI) based on preclinical mouse models and preliminary observations in limited patient series. Furthermore, early stud...

    Authors: Nicola A. Thompson, Grant D. Stewart, Sarah J. Welsh, Gary J. Doherty, Matthew J. Robinson, B. Anne Neville, Kevin Vervier, Simon R. Harris, David J. Adams, Katy Dalchau, David Bruce, Nikolaos Demiris, Trevor D. Lawley and Pippa G. Corrie
    Citation: BMC Cancer 2022 22:99
  9. Colorectal cancer (CRC) is still one of the most common types of cancer in the world, and the gut microbiome plays an important role in its development. The microbiome is involved in the carcinogenesis, format...

    Authors: Martina Rebersek
    Citation: BMC Cancer 2021 21:1325
  10. There is a growing level of interest in the potential role inflammation has on the initiation and progression of malignancy. Notable examples include Helicobacter pylori-mediated inflammation in gastric cancer an...

    Authors: Emily McIlvanna, Gerard J. Linden, Stephanie G. Craig, Fionnuala T. Lundy and Jacqueline A. James
    Citation: BMC Cancer 2021 21:1212
  11. Esophageal squamous cell carcinoma (ESCC) is the major type of esophageal cancer in China. The role of the bacteria present in ESCC tissue in neoplastic progression has not been fully elucidated. This study ai...

    Authors: Zhen Li, Chao Shi, Jiawen Zheng, Yongjun Guo, Taibing Fan, Huan Zhao, Dongdong Jian, Xiaolei Cheng, Hao Tang and Jie Ma
    Citation: BMC Microbiology 2021 21:301
  12. Many clinical trials have assessed the effect and safety of monoclonal antibodies (MAbs) in combination with proteasome inhibitors or immunomodulators plus dexamethasone/prednisone for the treatment of multipl...

    Authors: Wu Ye, Xia Wu, Xiaoyan Liu, Xue Zheng, Jili Deng and Yuping Gong
    Citation: BMC Cancer 2021 21:994
  13. Colorectal cancer (CRC) screening reduces CRC incidence and mortality. However, current screening methods are either hampered by invasiveness or suboptimal performance, limiting their effectiveness as primary ...

    Authors: Ane Sørlie Kværner, Einar Birkeland, Cecilie Bucher-Johannessen, Elina Vinberg, Jan Inge Nordby, Harri Kangas, Vahid Bemanian, Pekka Ellonen, Edoardo Botteri, Erik Natvig, Torbjørn Rognes, Eivind Hovig, Robert Lyle, Ole Herman Ambur, Willem M. de Vos, Scott Bultman…
    Citation: BMC Cancer 2021 21:930
  14. Colorectal cancer which is related to genetic and environmental risk factors, is among the most prevalent life-threatening cancers. Although several pathogenic bacteria are associated with colorectal cancer et...

    Authors: Sara Ebrahimzadeh, Hossein Ahangari, Alireza Soleimanian, Kamran Hosseini, Vida Ebrahimi, Tohid Ghasemnejad, Saiedeh Razi Soofiyani, Vahideh Tarhriz and Shirin Eyvazi
    Citation: BMC Microbiology 2021 21:218
  15. Though the gut microbiome has been associated with efficacy of immunotherapy (ICI) in certain cancers, similar findings have not been identified for microbiomes from other body sites and their correlation to t...

    Authors: Justin Chau, Meeta Yadav, Ben Liu, Muhammad Furqan, Qun Dai, Shailesh Shahi, Arnav Gupta, Keri Nace Mercer, Evan Eastman, Taher Abu Hejleh, Carlos Chan, George J. Weiner, Catherine Cherwin, Sonny T. M. Lee, Cuncong Zhong, Ashutosh Mangalam…
    Citation: BMC Cancer 2021 21:808
  16. Most NSCLCs metastasised out of the lungs at the time of diagnosis and cannot be surgically removed . Cytotoxic chemotherapy drugs have become the main treatment in recent decades, especially in patients with ...

    Authors: Qing Xia, Guojie Chen, Yanbei Ren, Tiansheng Zheng, Changxing Shen, Ming Li, Xiangyun Chen, Hong Zhai, Zhuang Li, Jianfang Xu, Aiqin Gu, Meiling Jin and Lihong Fan
    Citation: BMC Cancer 2021 21:721
  17. The gut microbiota influences many aspects of host physiology, including immune regulation, and is predictive of outcomes in cancer patients. However, whether conventional myelosuppressive chemotherapy affects...

    Authors: Lito E. Papanicolas, Sarah K. Sims, Steven L. Taylor, Sophie J. Miller, Christos S. Karapetis, Steve L. Wesselingh, David L. Gordon and Geraint B. Rogers
    Citation: BMC Cancer 2021 21:591
  18. Emerging evidence implicates the gut microbiome in liver inflammation and hepatocellular carcinoma (HCC) development. We aimed to characterize the temporal evolution of gut dysbiosis, in relation to the phenot...

    Authors: J. Behary, A. E. Raposo, N. M. L. Amorim, H. Zheng, L. Gong, E. McGovern, J. Chen, K. Liu, J. Beretov, C. Theocharous, M. T. Jackson, J. Seet-Lee, G. W. McCaughan, E. M. El-Omar and A. Zekry
    Citation: BMC Microbiology 2021 21:113
  19. Triazole, polyene, and echinocandin antifungal agents are extensively used to treat invasive fungal infections (IFIs); however, the optimal prophylaxis option is not clear. This study aimed to determine the op...

    Authors: Huilan Zeng, Zhuman Wu, Bing Yu, Bo Wang, Chengnian Wu, Jie Wu, Jing Lai, Xiaoyan Gao and Jie Chen
    Citation: BMC Cancer 2021 21:404
  20. Composition and maintenance of the microbiome is vital to gut homeostasis. However, there is limited knowledge regarding the impact of high doses of radiation, which can occur as a result of cancer radiation t...

    Authors: Raj Kalkeri, Kevin Walters, William Van Der Pol, Braden C. McFarland, Nathan Fisher, Fusataka Koide, Casey D. Morrow and Vijay K. Singh
    Citation: BMC Microbiology 2021 21:93
  21. Increase in the number of infections caused by Gram-negative bacteria in neutropenic cancer patients has prompted the search for novel therapeutic agents having dual anticancer and antimicrobial properties. Ba...

    Authors: Preeti Sharma, Sumanpreet Kaur, Bhupinder Singh Chadha, Raminderjit Kaur, Manpreet Kaur and Sukhraj Kaur
    Citation: BMC Microbiology 2021 21:39
  22. Alteration in gut microbiota has been recently linked with childhood leukemia and the use of chemotherapy. Whether the perturbed microbiota community is restored after disease remission and cessation of cancer...

    Authors: Ling Ling Chua, Reena Rajasuriar, Yvonne Ai Lian Lim, Yin Ling Woo, P’ng Loke and Hany Ariffin
    Citation: BMC Cancer 2020 20:151
  23. The gut microbiota is an important modulator of immune, metabolic, psychological and cognitive mechanisms. Chemotherapy adversely affects the gut microbiota, inducing acute dysbiosis, and alters physiological ...

    Authors: Julie M. Deleemans, Faye Chleilat, Raylene A. Reimer, Jan-Willem Henning, Mohamad Baydoun, Katherine-Ann Piedalue, Andrew McLennan and Linda E. Carlson
    Citation: BMC Cancer 2019 19:1243
  24. Mouse and human studies support the promise of dry beans to improve metabolic health and to lower cancer risk. In overweight/obese patients with a history of colorectal polyps or cancer, the Beans to Enrich th...

    Authors: Xiaotao Zhang, Gladys Browman, Wesley Siu, Karen M. Basen-Engquist, Samir M. Hanash, Kristi L. Hoffman, Pablo C. Okhuysen, Paul Scheet, Joseph F. Petrosino, Scott Kopetz and Carrie R. Daniel
    Citation: BMC Cancer 2019 19:1233
  25. Breast cancer ranks first in women, and is the second cause of death in this gender. In addition to genetics, the environment contributes to the development of the disease, although the factors involved are no...

    Authors: Julio Plaza-Díaz, Ana I. Álvarez-Mercado, Carmen M Ruiz-Marín, Iris Reina-Pérez, Alejandro J. Pérez-Alonso, María Belén Sánchez-Andujar, Pablo Torné, Tania Gallart-Aragón, María Teresa Sánchez-Barrón, Saturnino Reyes Lartategui, Federico García, Natalia Chueca, Ana Moreno-Delgado, Katia Torres-Martínez, María José Sáez-Lara, Cándido Robles-Sánchez…
    Citation: BMC Cancer 2019 19:495
  26. A causal association has been suggested between certain bacteria and colorectal cancer (CRC). Only a few studies have, however, investigated the presence of these bacteria directly in colon tissue with conflic...

    Authors: Caspar Bundgaard-Nielsen, Ulrik T. Baandrup, Lars P. Nielsen and Suzette Sørensen
    Citation: BMC Cancer 2019 19:399